Categories

Business Ideas
Business Opportunities
Corporate
Home Business
International Business
Management
Online Business
Public Company
Public Relations
Small Business

Popular Articles

GlaxoSmithKline gets notice for ad campaign
The Drug Controller General of India (DCGI) has issued a show-cause notice to GlaxoSmithKline Pharmaceuticals (GSK) for launching an advertisement campaign in the national media on cervical cancer vaccine Cervarix.

Fiat to unveil small car for India in 2012
Fiat India Automobile Ltd (FIAL) is developing a new compact car for the domestic market, which will be unveiled in 2012. The car, being developed for the Indian market in Fiat’s facilities in Turin, Italy, will incorporate inputs from Tata Motors. FIAL is a 50:50 joint venture between Fiat Group of Italy and Tata Motors.

News of the day

Sun Pharma settles patent dispute with Astra Zeneca
Sun Pharmaceutical Industries has settled a patent dispute with MedImmune, a unit of drug major Astra Zeneca, to dismiss an ongoing litigation in a US District Court. This was on patent rights of Ethyol (amifostine), a drug used to reduce toxicities associated with chemotherapy and radiation in head and neck cancers.
Corporate

Exide Industries June qtr net up 49% at Rs 122 cr

Battery major Exide Industries today said its net profit rose by 48.90 per cent to Rs 122.40 crore for the quarter ended June 30, 2009, over the same period last year. - Exide net rises 9% - J&K Bank turns negative - Cipla hits fresh 52-week high, gains 2% - Volatile Sensex ends flat - Bajaj Auto Finance slips 4% on profit taking - Infotech Enterprises up 4% on profit surge The company had a net profit of Rs 82.20 crore for the same period ended June 2008, Exide Industries said in a filing to the Bombay Stock Exchange (BSE). However, the total income of the company declined to Rs 903.46 crore in the latest quarter, against Rs 908.45 crore in the same quarter a year ago. Shares of Exide Industries today closed at Rs 70.60 on the BSE, up 0.93 per cent from previous close.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009